Physician profile
Leanne Olshavsky
NPI 1134318561
$1,673.82
in general payments reported to CMS, 2019-2025
20 companies · $250 in 2025
The $250 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,092 · 2020: $42.90 · 2021: $38.24 · 2022: $76.49 · 2023: $87.17 · 2024: $86.60 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $250 · Food and Beverage: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $250.00 |
| Food and Beverage | $173.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $896.97 | 2019 | |
| Hologic Sales and Service, LLC | $250.00 | 2025 | Myosure Tissue Removal Device |
| Gynesonics, INC. | $76.49 | 2022 | |
| Axonics, INC. | $72.55 | 2023 | Axonics |
| Coopersurgical, INC. | $49.26 | 2019-2023 | Supercut Hysterectomy Scissors |
| Astellas Pharma US INC | $41.05 | 2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $37.81 | 2019-2020 | |
| Therapeuticsmd, INC. | $37.11 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $32.34 | 2019 | |
| Organon LLC | $28.62 | 2024 | |
| Roche Diagnostics Corporation | $22.98 | 2019 | |
| Abbvie INC. | $16.93 | 2024 | |
| Molnlycke Health Care US, LLC | $16.82 | 2019 | |
| Daiichi Sankyo INC. | $16.39 | 2019 | |
| Mallinckrodt Enterprises LLC | $15.57 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $14.48 | 2021 | |
| Conmed Corporation | $13.14 | 2019 | |
| Duchesnay USA Incorporated | $13.10 | 2020 | |
| Avion Pharmaceuticals | $11.33 | 2019 | |
| Merck Sharp & Dohme LLC | $10.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leanne Olshavsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.